1p/19q testing has no significance in the workup of glioblastomas

AIMS: To determine whether testing for isolated 1p or 19q losses, or as a codeletion, has any significance in the workup of glioblastomas (GBMs). METHODS: Upfront 1p/19q testing by fluorescence in situ hybridization (FISH) and/or polymerase chain reaction (PCR)-based loss of heterozygosity (LOH) was...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Clark, K. H., Villano, J. L., Nikiforova, M. N., Hamilton, R. L., Horbinski, C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4095883/
https://ncbi.nlm.nih.gov/pubmed/23363074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nan.12031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky